# NIH grant: Boston University Clinical and Translational Science Institute (1UM1TR005308-01A1) — retained record

> Retained us-gov-api record from us-gov-api:nih-reporter.

Canonical: https://highsignal.app/data/records/1666e8f7fb384dc5

[← sources](https://highsignal.app/data)


source: [us-gov-api](https://highsignal.app/data/us-gov-api) (us-gov-api:nih-reporter)  published 2026-08-22 00:00 ingested 2026-08-24 06:47

[original source ↗](https://reporter.nih.gov/project-details/1UM1TR005308-01A1)

## retained text



```
NIH grant 1UM1TR005308-01A1: Boston University Clinical and Translational Science Institute
Institute: {'code': 'TR', 'abbreviation': 'NCATS', 'name': 'National Center for Advancing Translational Sciences', 'admin_org_id': '12500062', 'admin_funding_url': ''}. PI: MEGAN H BAIR-MERRITT. Award: $5801798.
Start: 2026-08-22T00:00:00.
The Boston University (BU) CTSI hub sits at the nexus of a research-intensive university, New England’s
largest essential hospital system, and the Veterans Health Administration’s most prominent research system.
Established in 2008, the hub is comprised of BU, partner Boston Medical Center Health System (with its 3
hospitals and 13 affiliated Community Health Centers) and collaborator the Veterans Affairs Boston Healthcare
System (with its 3 campuses and 7 affiliated health clinics). Key community stakeholders new to our
application include the Boston Public Health Commission, Massachusetts League of Community Health
Centers and Veteran advisory groups affiliated with the Center for Health Optimization & Implementation
Research at VA Boston. We are uniquely poised in this outstanding environment to catalyze translational
science to speed the discoveries that improve health across populations. The BU CTSI has a legacy of
delivering effective programs that improve the quality of health care and bring new treatments to patients from
across the economic spectrum. In this next funding period, the BU CTSI will directly target and overcome
translational science roadblocks to substantively advance translational science via an innovative thematic
approach “Science without Walls”. We will leverage our hub’s unique strengths in regenerative medicine, data
science, and implementation science as well as our ownership of nationally renowned longitudinal datasets.
We will accelerate health-related technologies, methodologies, novel data science and other programs that
expand scientific boundaries to improve health. We will train our research workforce to embody the
characteristics of a translational scientist, and will continue to build trust and enhance collaborations with
existing and new communities. The BU CTSI Strategic Goals are to:
GOAL 1. Disrupt the translational research pipeline and processes with creative approaches to overcome
translational barriers with the goal of speeding research that improves health and promotes well-being.
GOAL 2. Develop the clinical translational research workforce of the future through novel training programs for
our research community with a focus on research professional staff and community members.
GOAL 3. Employ rigorous evaluation and CQI methods to assess the impact of BU CTSI programs on
individual scientists and mentors, health system infrastructure and care delivery, while disseminating
innovative improvement tools and approaches to other hubs and beyond.
The BU CTSI’s mission is to improve health and well-being of all populations, by advancing innovative
translational science that disrupts the barriers that impede the transition from bench to bedside. Ensuring that
our new programs are sustainable, generalizable, efficient, and shared across the CTSA Program and beyond
is core to all activities.
```



document fetched 2026-08-30 02:46